Variants affecting the function of different subunits of the BAF chromatin remodelling complex lead to various neurodevelopmental syndromes including Coffin-Siris syndrome.
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nucleosomes and recognize post-translational histone modifications. 16, [18] [19] [20] They are highly conserved structures containing a zinc binding motif with Cys4-His-Cys3 architecture (C4HC3) that anchors two Zn 2+ ions. 21 DPF2 was first identified as an early apoptosis gene in mouse myeloid cells. 22 Recently, its inhibitory role in myeloid differentiation via interaction with RUNX1 was reported, possibly mediated by the BAF-complex. 18 Furthermore, DPF2 modulates the association between the BRM-type BAF complex and Rel/p52 to activate the noncanonical NF-kB pathway supporting oncogenesis and promotes the ubiquitination and degradation of OCT4, a crucial stem cell pluripotency factor. 16, 23 The index case (Individual 1) was a 10-year-old boy from France clinically suspected to have CSS with coarse facial features, global developmental delay, mild intellectual disability, speech delay (first words at 48 months and whole sentences at 84 months), stereotypic behavior, feeding problems for 1-2 years starting at the age of 6 months and muscular hypotonia. The boy was able to walk after the age of 17 months. Hypoplasia of the fourth and fifth toenails and brachydactyly of the fifth fingers were also observed ( Figure 2 , Table 1 and S1). Chromosomal microarray analysis did not reveal any pathogenic copy number variant and Sanger sequencing of six genes associated with CSS and Nicolaides-Baraitser syndrome (NCBRS, MIM: 601358), SMARCA4, SMARCB1, SMARCE1, ARID1B, ARID1A and SMARCA2 (MIM: 600014), showed no variant explaining the observed phenotype (Supplemental note and Table S2 ). Subsequent trio exome sequencing on an Illumina HiSeq 2500 system after enrichment with the SureSelect Target Enrichment v5 technology (Agilent Technologies, Santa Clara, CA) revealed the previously unreported heterozygous de novo missense variant c.827G>T in exon 8 of DPF2, resulting in a substitution of cysteine to phenylalanine at position 276 (p.(Cys276Phe)). The nucleotide change affected a highly conserved amino acid in the PHD1 finger ( Figure 1 ). The variant was not described in the Genome Aggregation Database (gnomAD) and was predicted computationally to be deleterious (Table S3 ).
Additional evidence for the correlation of the identified DPF2 variant with the clinical phenotype was provided by a large trio exome-wide study on 4,293 children with severe, undiagnosed developmental disorders (DDD). 24 From the de novo variants reported we extracted two additional heterozygous missense variants in female individuals originating from England, c.990C>G (p.(Cys330Trp)) in exon 9 (Individual 2; DDD4K.02108) and 6 c.1049G>A (p.(Arg350His)) in exon 10 (Individual 3; DDD4K.03804) of DPF2, respectively.
Further interrogation of the DDD resource at a later stage for subjects with craniosynostosis (Datafreeze 3: 7,833 trios and 1,792 singletons) revealed two further individuals, tested with trio exome sequencing, with missense substitutions c.1037A>G (p.(Asp346Gly)) in exon 10 (Individual 4; DDDP126054) and c.1105T>C (p.(Trp369Arg)) in exon 11 (Individual 5; DDDP100312) of DPF2. All four variants locate in PHD2 finger affecting highly conserved amino acids (Figure 1 ). They were likewise not present in the gnomAD and the computer based prediction programmes classified them as deleterious (Table S3 ).
Based on further collaborations and by employing the web-based matching platform GeneMatcher 25 we could identify another 3 individuals with de novo DPF2 likely gene disrupting (LGD) variants, all located in either PHD domain. These individuals underwent trio exome sequencing in the respective institutions. [26] [27] [28] Premature termination codons occurring at least 50 bp upstream of the last exon-exon junction have been described to escape NMD. 29, 30 Two of the variants fell under this category. Sequencing of mRNA for the variant c.1099+1G>A (Individual 7) affecting the consensus GT splice-donor site in intron 10 showed an heterozygous aberrant transcript with skipping of exon 10 (r.1018_1099del). This resulted in a frameshift and a premature stop codon after 12 amino acids (p.Asp340Glufs*12) ( Figure 1A , S1A und S1B). RNA expression analysis also confirmed the 8 bp heterozygous deletion c.1066_1073del in exon 10 of DPF2 (Individual 8), predicted to cause a frameshift with a premature termination codon after 5 residues (p.Cys356Profs*5), virtually excluding NMD ( Figure 1A , S1C and S1D). The third possible LGD variant was a de novo splice-donor alteration c.904+1G>T identified in Individual 6 ( Figure 1A ). An RNA sample from this individual was not available. This variant is located >50 bp to the last exon-exon junction.
However, it is predicted to disrupt the affected canonical splice-donor site of intron 8 (Table   S3 ), which likely leads to skipping of exon 8 (r.776_904del). The predicted skipping would result in a likely stable, in-frame insertion-deletion (p.(Ser259_Gly302delinsTrp)) affecting several highly conserved amino acids of PHD1. Apart from the DPF2 variants, the broad genetic evaluation revealed additional rare SNVs or CNVs in all individuals except Individuals 4 and 8. However, these could not explain the clinical phenotype either due to their functional and spatial properties or the fact that they were inherited from an unaffected parent. Additional information about these variants is presented in the supplemental note (also see Table S2 ). 7 According to the pLI (probability of LoF intolerance) value in ExAC (version 0.3.1 accessed on 2017-09-10), DPF2 seems to be highly intolerant to heterozygous loss-of-function (pLI=1.00) and also missense (Z score=3.30) variants. 31, 32 Moreover, missense variants reported in ExAC are located mainly in the N-terminal domain of DPF2, whereas their frequency in PHD fingers is markedly lower ( Figure 1A ). Microdeletions encompassing DPF2 have not been associated with a clinical phenotype to date. 33 In the Database of Genomic Variants (DGV) 34 two deletions of 149.5 and 242.1 kb including DPF2 were described.
The clinical phenotype of Individuals 2-8 was similar to that of Individual 1 and consistent with the phenotypic spectrum of CSS (Table 1 and S1). Global developmental delay was present in all individuals. Three Individuals exhibited moderate (Individuals 2, 3 and 5), one mild (Individual 8) and another two borderline intellectually disability (Individuals 4 and 7). respectively) and fifth finger clinodactyly (Individuals 2, 5, 8) (see also Figure 2 ).
As known from individuals with ARID1B variants the CSS facial phenotype can be highly variable. 35 Most of the individuals bearing DPF2 variants presented with coarse facies. The most consistent facial features were sparse scalp hair (6/8), down-slanting palpebral fissures Evaluation of growth parameters revealed that 5/8 children presented with short stature although in one, height normalized during puberty (Individual 2). In total 4 individuals showed evidence of muscular hypotonia and 5 individuals manifested feeding problems.
Behavioral anomalies varied across individuals, including stereotypic movements (Individual 1), temper tantrums, obsessive and compulsive behavior, hyperactivity, poor sleep pattern and stereotypic movements of hands (Individual 3), fixations, temper tantrums, competitivity and clinically suspected autism (Individual 5). Furthermore, hearing impairment was described in 8 4 affected children. Notably, 2 individuals were diagnosed with sagittal craniosynostosis (Individuals 4 and 5). Individual 7 was clinically diagnosed with trigonocephaly, but no radiographic imaging was performed to confirm a metopic craniosynostosis. To our knowledge craniosynostosis is extremely rare in CSS, as it was previously described only in two individuals with an ARID1B variant and a 2p25 chromosome deletion encompassing SOX11, respectively. 12, 36 However, it is unclear whether it is a consistent manifestation in individuals bearing DPF2 variants, since both Individuals 4 and 5 were selected from DDD study based on this anomaly. Other common features included broad thumbs (3/8) and prominent fetal fingertip pads (3/8) . Finally, mild to severe constipation was diagnosed in 6 and recurrent otitis media in 4 out of 8 affected children. Three individuals underwent cerebral magnetic resonance imaging (MRI) showing right cerebellar hemisphere atrophy (Individual 2), small pituitary gland (Individual 6) and Arnold-Chiari malformation I (Individual 7). No corpus callosum anomalies were noted ( Table 1 and S1). Taken together the clinical presentation of these individuals significantly overlaps with that seen in CSS individuals. However, Coffin-Siris syndrome was either clinically suspected or considered as differential diagnosis only for Individuals 1, 3, 7 and 8. The remaining Individuals 2, 4, 5 and 6 were not clinical diagnosed with Coffin-Siris syndrome highlighting the value of trio exome sequencing as a clinical tool. Further phenotype/genotype correlation is not possible at the moment due to the relatively small number of individuals.
In order to assess the effects of the DPF2 missense variants on protein function and structure we used as reference a model based on the crystal structure of DPF2 and DPF3 bound to a histone peptide ( Figure 1B ). 19, 37 All 5 identified variants affect highly conserved residues within the C-terminal PHD1 and PHD2 motifs (PHD1: amino acids 272-327 and PHD2: amino acids 329-374), which are responsible for the recognition of histone modifications.
Strikingly, all affected amino acids are in very close proximity to a zinc binding site, likely disrupting these sites and consequently the protein structure. This is especially evident for the affected tryptophan (Trp369) and both cysteine residues (Cys276 and Cys330), as they directly disrupt a highly conserved residue of the C4HC3 motif, which anchors the two zinc atoms of the PHD fingers in a cross-brace topology (see also Figure 1C and 1D). 21, 38 Interestingly, the affected Asp346 lies on the negatively charged PHD2 surface in the H3 peptide binding site and directly interacts with the H3 acetylated at lysine 14 (H3K14ac). 18 The remaining affected residues showed no direct interaction, but due to the possible loss of 9 the zinc binding sites and the altered conformation of PHD fingers it can be speculated that the binding to H3 is weakened or even abolished ( Figure 1B ). PHD fingers differentially recognize unmodified or methylated and acetylated lysine as well as unmodified arginine residues in histone tails. 19, 21, 37, 39 Proteins containing these motifs are implicated in the recruitment of chromatin remodellers and transcription factors. 21 The tandem PHD finger domain of DPF3, a DPF2 paralog, was shown to recruit BAF chromatin remodelling complex to regulate transcription by targeting N-terminal tails of unmodified as well as modified acetylated and methylated lysines of histone H3 and H4. Variants disrupting the structure of one of the PHD fingers lead to abolition of binding to unmodified H3 and H3
modifications. Yet a single integral PHD is still able to recognise unmodified H4 or acetylated lysines of H4. 37, 39 Similarly, intact DPF2, binds to unmodified and acetylated H4 as well as to unmodified, acetylated and methylated H3 with H3 acetylated at lysine 14 (H3K14ac) increasing the affinity, while H3 methylated at lysine 4 (H3K4me3) reduces or inhibits the interaction. 18, 37 It was recently reported that the tandem PHD finger of DPF2 is also responsible for the epigenetic regulation of transcription through the identification of rare histone modifications such as propionylation, butyrylation and especially crotonylation, the latter leading to a higher interaction with DPF2 than acetylation. 19 In a recent study binding of an experimental construct bearing mutations in both PHD fingers of DPF2 to H3 and H4 histone tails was abolished, whereas interaction to BAF-complex members was not, suggesting that the major impact of these mutations is the loss of histone binding. 18 In order to experimentally investigate the impact of DPF2 missense variants on histone interactions we first generated GST-tagged wild type DPF2 fusion protein (GST-DPF2) as well as expression plasmids harbouring 3 missense substitutions found in DPF2 individuals, Cys276Phe in PHD1 (GST-DPF2 C276F) and Cys330Trp (GST-DPF2 C330W) and
Arg350His (GST-DPF2 R350H) in PHD2 finger. The two remaining missense variants Asp346Gly and Trp369Arg were added at the latest stage of our study after the completion of the functional analyses. To perform histone binding assays we produced recombinant GST proteins using a glutathione-S-transferase pull-down system. The interaction with the histones was assessed using H3 and H4 biotinylated histone peptides, unmodified or harboring specific modifications. We observed a strong binding of the wild type DPF2 to unmodified as well as acetylated or methylated H3 (unmodified H3, H3K14ac, H3K9ac, H3K9/14ac, H3K9me2, H3K9me3). Both H3 trimethylated at lysine 4 (H3K4me3) and di/trimethylated at lysine 27 (H3K27me2/3) showed either no or very weak interaction with DPF2. Unmodified and acetylated H4 at lysine 12 also showed binding to DPF2 albeit weaker. Reciprocally, all three mutants abolished (H3K14ac, H3K9/14ac) or strongly attenuated (unmodified H3, H3K9ac, H3K9me2 and H3K9me3) the binding to H3, but not to unmodified and acetylated H4 ( Figure   3A ). These data suggest that the 3 missense variants examined indeed impair the structural integrity of either PHD1 or PHD2 resulting in the aberrant reading of H3 histone modifications. Additionally, it confirms that the tandem PHD1/2 finger works as an integral unit for the identification of H3 and H3 modifications for DPF2, as previously described for DPF3. 39 Considering that DPF2 is, as DPF3, a subunit of BAF chromatin remodelling complex, we suggest that the identified missense substitutions in nucleosome targeting modules disrupt the tandem PHD finger functional cohesion and capacity of recognizing H3 histone modifications leading to misreading from the BAF complex and epigenetic deregulation of gene transcription as shown for DPF3. 39 Next, we determined whether the identified missense variants impair the sub-cellular localization of DPF2. To this end, we employed immunofluorescence confocal microscopy in HEK293 cells overexpressing GFP-tagged DPF2 (GFP-DPF2) or the PHD mutants. All transfected proteins exhibited similar levels of expression ( Figure 3D ). Both wild type and mutant proteins showed exclusively nuclear localization. This was diffuse for wild type DPF2, while approximately 30% of cells expressing the missense variant in PHD1 (GFP-DPF2 C276F) and 50% of those with the missense variant in the second amino acid of PHD2 (EGFP-DPF2 C330W) formed distinct aggregate-like nuclear structures which were negative for DAPI staining ( Figure 3B and 3C). The percentage of cells exhibiting these abnormal nuclear accumulations peaked at 72h post transfection ( Figure 3C ). The mutant harboring the alteration in the middle of PHD2 finger (GFP-DPF2 R350H) had only marginal effect on the formation of aggregates ( Figure 3B and 3C). In order to exclude that the formed aggregates are technical artifacts relating to the GFP-tagged protein we complementarily used a FLAG expression vector. The results obtained were highly comparable ( Figure. S2A and S2B). The formation of aggregates was further validated in a second cell line, COS7 cells ( Figure S2C ).
The observation of nuclear aggregates of DPF2 with disrupted PHD finger structure is in accordance with a previous report using HeLa cells to investigate the regulation of OCT4 by DPF2. 23 Protein misfolding may lead to protein aggregation, a major characteristic of several disorders including neurodegenerative conditions. 40 We therefore speculate that the nuclear aggregate formation observed in the two DPF2 mutants correlates with aberrant protein conformation, which may lead to protein dysfunction. Strikingly, in HEK293 cells co-transfection experiments showed that the wild type GFP-DPF2 was recruited to the aggregates formed by C276F and C330W FLAG-DPF2 mutants. This recruitement was accompanied by a reduction in cells showing aggregates as compared to those co-expressing the FLAG-DPF2 mutants with control empty GFP ( Figure S3A and S3B). Furthermore, co-expressed FLAG-BRG1 co-localized with the two GFP-DPF2 mutants within the aggregate-like structures ( Figure S3C ). The recruitment of wild type DPF2 to the nuclear aggregates formed by mutant DPF2 proteins as well as the concomitant reduction of aggregate-exhibiting cells suggest an interaction between wild type and mutant DPF2. This would be in line with a dominant negative pathomechanism. In addition, the sequestration of the BAF complex core subunit BRG1 in the aggregates suggests that these DPF2 mutations could lead to disruption of the physiological interactome of the BAF complex. Further experiments are necessary to elucidate if the nuclear aggregation phenotype is associated with the alterations directly affecting amino acids of the C4HC3 motif, since the variant Arg350His with the minor effect is the only one of the three studied substitutions located outside of it.
Variants in the two paralog BAF subunits of DPF2 (DPF1 and DPF3) have not been associated with disease in humans to date. Yet alterations in genes encoding chromatin-related PHD-containing proteins, some of which even directly target the evolutionary conserved PHD motifs, have been implicated in many neurodevelopmental disorders. More specifically, [41] [42] [43] [44] [45] [46] Dysregulated PHD proteins are also involved in further human diseases ( Figure 1D , S4, S5B and Supplemental File S1). Interestingly some of the pathogenic mutations found in other PHD-containing proteins affect homologous protein residues which overlap to those altered in DPF2 individuals ( Figure S6 and Supplemental File S1).
In summary, the following lines of evidence support the pathogenicity of the identified DPF2 variants: 1) their de novo occurrence, 2) the PHD finger mutational hotspot 3) the intolerance of DPF2 and especially its tandem PHD finger domain to variation and 4) functional analyses of the missense alterations showing abolished or attenuated H3 binding and the formation of nuclear DPF2 aggregates. Despite the intolerance to loss-of-function variants evidenced by the high pLI value, haploinsufficiency seems unlikely as the annotation of deletions encomprassing DPF2 in normal population indicate that a complete loss of one allele may be neutral. In the contrary, the clustering of all variants within an evolutionary highly concerved region, as previously described for other BAF subunits (SMARCA4, SMARCA2, SMARCB1, SMARCE1), the nuclear aggregation phenotype as well as the recruitment of wild type DPF2 and BRG1 to the aggregates indicate a dominant negative effect. The results of the expression analysis of the splice-site and frameshift DPF2 variants found in individuals, suggesting that the truncated transcripts escape nonsense-mediated mRNA decay, further support the dominant negative hypothesis. Nevertheless, without protein analysis we can not completely exclude a truncated RNA or protein instability leading to a specific lossof-function of PHD fingers at least for the truncating variants.
In conclusion, we identified 8 individuals with CSS phenotype bearing de novo variants in the DPF2 PHD finger domains. Our study further confirms the crucial role of PHD finger containing proteins in human neurodevelopmental disorders and strengthens the association of variants affecting the function of BAF chromatin remodelling complex subunits with the aetiology of CSS. 13 
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(D)
Amino-acid sequence alignment of DPF2 and putative human paralog proteins with similar tandem PHD fingers showing conservation of the C4HC3 signature (see also Figure   S5B and Supplemental File S1, sheet ´PHD_finger_proteins_(PHF)´). Protein sequences were obtained from NCBI and ClustalW 47 , the msa package 48 Abbreviations aa = amino acids. GST-tagged wild type DPF2 and mutants were generated by N-terminal subcloning from the pEGFP-C3 into a pGEX4T1(GST) vector via BglII/SalI restriction sites (Table S4) 500mM KCl, 0.2mM DTT, 1mM EDTA, and 10% Glycerol for 2 h and the same buffer with 60% Glycerol ON. Histone peptide-binding assays were performed as described in Lange et al. 39 Biotinylated histone peptides were purchased from Millipore (unmodified H3, 12-403; H3K9ac, 12-431; H3K14ac, 12-425; H3K9/14ac, 12-402; H3K9me2, 12-430; H3k9me3, 12-568; H3K4me3, 12-460, H3K27me2, 12-566; H3K27me3, 12-565; unmodified H4, and Tebu-bio (H4K12ac, 12-0032; H4K16ac, 12-0033). were generated by mutagenesis PCR. Primers used for cloning and mutagenesis are described in Table S4 . Human embryonic kidney fibroblasts HEK293 were grown as described in Bohring-Opitz syndrome, characterized by severe psychomotor delay, feeding difficulties, small size at birth and microcephaly. 51 Recently the intellectual disability syndrome due to ASXL3 mutations was recognized as a distinct clinical phenotype, called Bainbridge-Ropers syndrome (MIM: 615485). 52 Nevertheless, all pathogenic mutations reported until recently are truncating and are located within two evolutionarily conserved regions with phosphorylation sites and a serine-rich motif, located upstream of the identified substitution in individual 5. 51 Taking the aforementioned data together, the missense alteration c.3078G>C (p.(Lys1026Asn)) in ASXL3 seems to be a rare variant not affecting function and we thus did not consider it as relevant to the phenotype. syndrome, including asplenia. 53, 54 Although the mother was healthy without any cardiac anomalies and the bicuspid aortic valve as well as the dilated ascending aorta diagnosed in individual 6 are not the major cardiac manifestations of patients with this mutation, we cannot exclude a possible contribution to the described cardiac anomalies. Yet the remaining clinical features cannot be explained by this aberration. Moreover, microarray analysis revealed a de novo duplication of 652 kb (chrX:92,416,787-93,069,211) in Xq21.32, encompassing two genes; FAM133A without OMIM phenotype and NAP1L3 (MIM: 300117), the latter gene being homologous with the genes of nucleosome assembly protein family (NAPs) encoding for brain specific proteins. NAP1L3 is closely linked to a region (Xq21.3-q22) of genes responsible for X-linked intellectual disability, but to our knowledge neither NAP1L3 nor other members of NAP family have been implicated in developmental delay syndromes. 55 We characterized this as a variant of unknown significance (VUS), but given that the aberration is unlikely. Also, variants in SETD1B or in the other candidate genes in this region have not been associated with disease in humans to date; consequently the underlying mechanism of deletions in this region behind the clinical phenotype remains elusive. Finally, individual 7
presented with borderline ID without evidence of seizures or autistic behaviour which is not consistent with the phenotype described in patients with 12q24.31 microdeletions (Table S2 ). (A) Representative confocal immunofluorescence microscopy images of HEK293 cells expressing FLAG-tagged DPF2 and mutants. Note the formation of nuclear aggregate-like structures in cells transfected with the indicated mutants (columns 2-4) as compared to the wild type DPF2 (column 1). Top panel shows staining with antibody against FLAG and lower panel merged pictures with DAPI. Scale bar 10 µm. FLAG-tagged proteins were generated by subcloning from the pGEX4T1 vector into a pCMV-Tag2b (FLAG) vector via EcoRI/SalI restriction sites. Primers used for cloning and mutagenesis are described in Table S4 . Transfection with FLAG-tagged DPF2 plasmids and immunofluorescence were performed as described in Figure 3B , but using Lipofectamine (Invitrogen). Cells were incubated with mouse monoclonal anti-FLAG M2 primary antibody (Sigma-Aldrich) followed by incubation with goat anti-mouse conjugated to Alexa Fluor 488 (Life Technologies). (C) Representative confocal immunofluorescence microscopy images of HEK293 cells coexpressing GFP-tagged DPF2 and mutants together with FLAG-tagged BRG1 (Addgene). 58 Note the co-localization of BRG1 with the indicated mutants in the nuclear aggregates (columns 2-3). Top panel shows staining with antibody against FLAG and lower panel merged pictures with FLAG/GFP/DAPI. Scale bar 5 µm.
Figure S4. Cladogram of PHD finger domains used to find DPF2 paralog proteins.
To find putative human paralog proteins of DPF2 with similar tandem PHD fingers for the multiple amino-acid sequence alignment we compiled a list of known proteins with PHD finger domains (see also Supplemental File S1, sheet ´PHD_finger_proteins_(PHF)´) using different sources (see also Supplemental File S1, sheet ´data´) and extracted the amino acid sequence of their PHD finger domains based on the NCBI annotations using bedtools v2.26.0. 59 These sequences were then aligned using ClustalW 47 the msa package in R. 48 The cladogram was plotted using the ape package 60 and ggtree package in R. 61 The node for the first tandem PHD finger was marked in blue and the node for the second PHD finger was marked in green. Based on these results and the visual inspection of the protein domain structures the proteins DPF1 (NP_001128627.1), DPF3 (NP_001267471.1), KAT6A (NP_006757.2), KAT6B (NP_036462.2) and PHF10 (NP_060758.2) were selected as putative paralogs of DPF2 (NP_006259.1) and used for multiple sequence alignment ( Figure  1D and Figure S5B ).
Figure S5. Full multiple sequence alignment of DPF2 Orthologs and Paralogs.
(A) Full multiple sequence alignment of DPF2 orthologs. Protein sequences were obtained from the NCBI (see Supplemental File S1, sheet ´DPF2_orthologs´) and ClustalW 47 from the msa package 48 in R was used for alignment. (B) Full multiple amino-acid sequence alignment of DPF2 and putative human paralog proteins with similar tandem PHD fingers. Protein sequences were obtained and alignment was performed as described above (see Supplemental File S1, sheet ´PHD_finger_proteins_(PHF)´)
Figure S6. Multiple sequence alignment of PHD finger domains from intellectual disability associated genes with (likely) pathogenic missense variants from ClinVar
Protein sequences were obtained from the NCBI while missense variants of class 4 or 5 in genes associated with an intellectual disability phenotype in OMIM containing a PHD finger domain were obtained from ClinVar on 2017-11-26 (see Supplemental File S1, sheet ´PHD_finger_proteins_(PHF)´). Only missense variants in canonic PHD fingers (PHD finger 1-6 in sheet ´PHD_finger_proteins_(PHF)´) were considered. ClustalW 47 from the msa package in R 48 
